- Home
- MGPI vs CGEM Comparison
MGPI vs CGEM Comparison
Compare MGPI & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- CGEM
- Stock Information
- Founded
- MGPI 1941
- CGEM 2016
- Country
- MGPI United States
- CGEM United States
- Employees
- MGPI N/A
- CGEM N/A
- Industry
- MGPI Beverages (Production/Distribution)
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- CGEM Health Care
- Exchange
- MGPI Nasdaq
- CGEM Nasdaq
- Market Cap
- MGPI 633.7M
- CGEM 530.0M
- IPO Year
- MGPI 1988
- CGEM 2021
- Fundamental
- Price
- MGPI $30.16
- CGEM $7.75
- Analyst Decision
- MGPI Strong Buy
- CGEM Strong Buy
- Analyst Count
- MGPI 5
- CGEM 5
- Target Price
- MGPI $45.40
- CGEM $30.00
- AVG Volume (30 Days)
- MGPI 275.3K
- CGEM 324.2K
- Earning Date
- MGPI 07-31-2025
- CGEM 08-07-2025
- Dividend Yield
- MGPI 1.61%
- CGEM N/A
- EPS Growth
- MGPI N/A
- CGEM N/A
- EPS
- MGPI 0.50
- CGEM N/A
- Revenue
- MGPI $654,715,000.00
- CGEM N/A
- Revenue This Year
- MGPI N/A
- CGEM N/A
- Revenue Next Year
- MGPI N/A
- CGEM N/A
- P/E Ratio
- MGPI $59.60
- CGEM N/A
- Revenue Growth
- MGPI N/A
- CGEM N/A
- 52 Week Low
- MGPI $25.12
- CGEM $6.85
- 52 Week High
- MGPI $92.52
- CGEM $21.01
- Technical
- Relative Strength Index (RSI)
- MGPI 51.61
- CGEM 41.43
- Support Level
- MGPI $29.33
- CGEM $7.53
- Resistance Level
- MGPI $30.94
- CGEM $9.25
- Average True Range (ATR)
- MGPI 0.98
- CGEM 0.38
- MACD
- MGPI 0.13
- CGEM -0.13
- Stochastic Oscillator
- MGPI 72.64
- CGEM 13.02
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.